Literature DB >> 11032028

Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: similarities to retroviral RNA-protein interactions.

S Kubota1, S Kondo, T Eguchi, T Hattori, T Nakanishi, R J Pomerantz, M Takigawa.   

Abstract

The repressive effect of the 3'-untranslated region (3'-UTR) in human connective tissue growth factor/ hypertrophic chondrocyte specific 24 (ctgf/hcs24) mRNA on gene expression had been demonstrated in our previous study. Here, we identified a minimal RNA element in the 3'-UTR, which acts as a cis-acting element of structure-anchored repression (CAESAR). Deletion analyses of the 3'-UTR led us to minimize the element of 84 bases at the junction of the coding region and the 3'-UTR. The minimized RNA segment is predicted, and actually capable of forming a stable secondary structure in vitro. Mutational analyses disclosed a significant relationship between the predicted structure and repressive effect. The utility of CAESAR as a post-transcriptional regulatory element was represented by the fact that steady-state mRNA levels were not affected by CAESAR linked in cis, while protein levels from such a chimeric gene were markedly reduced. Of note, the CAESAR sequence exerted no effect, when it was placed upstream of the promoter. Finally, RNA gel electromobility-shift analyses demonstrated a nuclear factor that interacts with the folded CAESAR. Taken together, it was uncovered that CAESAR of ctgf is a novel post-transcriptional structured RNA regulatory element, probably acting through direct interactions with a nuclear factor as observed in retroviral RNA elements with certain proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032028     DOI: 10.1038/sj.onc.1203835

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  Regulation of CCN1 via the 3'-untranslated region.

Authors:  Yosuke Nakagawa; Masanao Minato; Kumi Sumiyoshi; Aya Maeda; Chikako Hara; Yurika Murase; Takashi Nishida; Satoshi Kubota; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2013-05-16       Impact factor: 5.782

3.  Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis.

Authors:  Abdellatif El-Seoudi; Tarek Abd El Kader; Takashi Nishida; Takanori Eguchi; Eriko Aoyama; Masaharu Takigawa; Satoshi Kubota
Journal:  J Cell Commun Signal       Date:  2017-03-25       Impact factor: 5.782

4.  The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts.

Authors:  A Leask; S Sa; A Holmes; X Shiwen; C M Black; D J Abraham
Journal:  Mol Pathol       Date:  2001-06

5.  Posttranscriptional regulation of chicken ccn2 gene expression by nucleophosmin/B23 during chondrocyte differentiation.

Authors:  Yoshiki Mukudai; Satoshi Kubota; Harumi Kawaki; Seiji Kondo; Takanori Eguchi; Kumi Sumiyoshi; Toshihiro Ohgawara; Tsuyoshi Shimo; Masaharu Takigawa
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

Review 6.  An early history of CCN2/CTGF research: the road to CCN2 via hcs24, ctgf, ecogenin, and regenerin.

Authors:  Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2017-10-26       Impact factor: 5.782

Review 7.  The sweet side of RNA regulation: glyceraldehyde-3-phosphate dehydrogenase as a noncanonical RNA-binding protein.

Authors:  Michael R White; Elsa D Garcin
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-11-12       Impact factor: 9.957

8.  The role of CCN2 in cartilage and bone development.

Authors:  Satoshi Kubota; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2011-02-14       Impact factor: 5.782

9.  Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?

Authors:  Andrew Leask; Sunil K Parapuram; Xu Shi-Wen; D J Abraham
Journal:  J Cell Commun Signal       Date:  2009-01-21       Impact factor: 5.782

10.  OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells.

Authors:  Takanori Eguchi; Ken Watanabe; Emilio Satoshi Hara; Mitsuaki Ono; Takuo Kuboki; Stuart K Calderwood
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.